Use

The Xpanded® Adult Movement Disorders Panel is a phenotype‑driven, comprehensive genetic test that employs whole‑exome capture and next‑generation sequencing with analysis targeted to a curated list of approximately 500 genes associated with adult‑onset movement disorders. It aids in identifying pathogenic and likely pathogenic variants relevant to diagnostic decision‑making. Variants of uncertain significance are generally not reported unless deemed appropriate, and benign/likely benign variants are excluded. Additionally, incidental findings with potential clinical impact (e.g., cancer, cardiac or metabolic risk genes) are disclosed to the ordering provider when identified.